Development of Biphenyl-Substituted Uracil-Based Hydroxamic Acids (UBHAs) as Potent HDAC Inhibitors with Pro-Apoptotic Activity in Leukemia and Prostate Cancer Cells
Journal of Medicinal Chemistry · 14.05.2026 · 69 (9) · 10060-10082
DOI: 10.1021/acs.jmedchem.5c02737 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 30.04.2026. Verfasst von Francesco Fiorentino und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemical Sciences, Sapienza University of Rome, Piazzale Aldo 5, 00185 Rome, Italy. Hauptthemen laut MEDLINE: Histone Deacetylase Inhibitors, Apoptosis, Hydroxamic Acids, Prostatic Neoplasms. Die Arbeit nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Sapienza Universit? di Roma, Associazione Italiana per la Ricerca sul Cancro, Ministero dell'Universit? e della Ricerca.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biochemical Sciences, Sapienza University of Rome, Piazzale Aldo 5, 00185 Rome, Italy.
- Department of Molecular Medicine, Sapienza University of Rome, Piazzale Aldo Moro 5, 00185 Rome, Italy.
- Gene Expression Laboratory, National Institute for Infectious Diseases, Lazzaro Spallanzani IRCCS, Via Portuense, 292, 00149 Rome, Italy.
- Department of Translational Medicine and Surgery, Università Cattolica del Sacro Cuore, Largo Francesco Vito, 1, 00168 Rome, Italy.
- Department of Drug Chemistry and Technologies, Sapienza University of Rome, Piazzale Aldo 5, 00185 Rome, Italy.
- TES Pharma S.r.l., Via P. Togliatti 20, Corciano, 06073 Perugia, Italy.
ORCID-Profile: Francesco Fiorentino, Antonello Mai, Dante Rotili
Förderung
- Sapienza Universit? di Roma
- Associazione Italiana per la Ricerca sul Cancro
- Ministero dell'Universit? e della Ricerca
Zitieren
APA
Fiorentino, F., Bontempi, G., Michetti, F., Pecci, V., Fabbrizi, E., Passeri, D., Corsetti, L., Farini, V., Casano, F., Gioiello, A., Di Sotto, A., Pellicciari, R., Del Bufalo, D., Trisciuoglio, D., Nanni, S., Strippoli, R., Mai, A., & Rotili, D. (2026). Development of Biphenyl-Substituted Uracil-Based Hydroxamic Acids (UBHAs) as Potent HDAC Inhibitors with Pro-Apoptotic Activity in Leukemia and Prostate Cancer Cells. Journal of Medicinal Chemistry, 69(9), 10060-10082. https://doi.org/10.1021/acs.jmedchem.5c02737
Vancouver
Fiorentino F, Bontempi G, Michetti F, Pecci V, Fabbrizi E, Passeri D, et al. Development of Biphenyl-Substituted Uracil-Based Hydroxamic Acids (UBHAs) as Potent HDAC Inhibitors with Pro-Apoptotic Activity in Leukemia and Prostate Cancer Cells. Journal of Medicinal Chemistry. 2026;69(9):10060-10082. doi:10.1021/acs.jmedchem.5c02737
BibTeX
@article{Fiorentino2026,
author = {Fiorentino, Francesco and Bontempi, Giulio and Michetti, Federica and Pecci, Valeria and Fabbrizi, Emanuele and Passeri, Daniela and Corsetti, Letizia and Farini, Valentina and Casano, Fabrizio and Gioiello, Antimo and Di Sotto, Antonella and Pellicciari, Roberto and Del Bufalo, Donatella and Trisciuoglio, Daniela and Nanni, Simona and Strippoli, Raffaele and Mai, Antonello and Rotili, Dante},
title = {Development of Biphenyl-Substituted Uracil-Based Hydroxamic Acids (UBHAs) as Potent HDAC Inhibitors with Pro-Apoptotic Activity in Leukemia and Prostate Cancer Cells},
journal = {Journal of Medicinal Chemistry},
year = {2026},
volume = {69},
number = {9},
pages = {10060--10082},
doi = {10.1021/acs.jmedchem.5c02737}
}
EUVIMED